From access to advocacy: Turning patients into brand champio...
Done right, DTP is not just filling scripts. It is building loyalty that turns satisfied patients into lifelong advocates.
Newsletters and Deep Dive digital magazine
Done right, DTP is not just filling scripts. It is building loyalty that turns satisfied patients into lifelong advocates.
Jazz's biliary tract cancer drug Ziihera and Lilly's Jaypirca for chronic lymphocytic leukaemia have been backed for NHS use in new NICE guidance.
A scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems.
Donald Trump has signed an executive order directing the FDA to reduce regulatory hurdles that stand in the way of bringing psychedelics to patients.
The revitalisation of GSK's Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple myeloma drug more widely.
Editor's Picks
Newsletters and Deep Dive
digital magazine